Abstract
IntroductionPoststroke spasticity (PSS) affects up to 40% of patients who had a stroke. Botulinum neurotoxin type A (BoNT-A) has been shown to improve spasticity, but the optimal timing of its...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have